c-MYC Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality with TRAIL

Cited 14 time in webofscience Cited 0 time in scopus
  • Hit : 285
  • Download : 0
DC FieldValueLanguage
dc.contributor.authorLee, Hoyeonko
dc.contributor.authorCha, Junghwako
dc.contributor.authorKim, Seon Kyuko
dc.contributor.authorPark, Junhyungko
dc.contributor.authorSong, Ki Hoonko
dc.contributor.authorKim, Pilnamko
dc.contributor.authorKim, Mi Youngko
dc.date.accessioned2019-02-21T01:26:13Z-
dc.date.available2019-02-21T01:26:13Z-
dc.date.created2018-09-06-
dc.date.issued2019-02-
dc.identifier.citationMOLECULAR CANCER RESEARCH, v.17, no.2, pp.544 - 554-
dc.identifier.issn1541-7786-
dc.identifier.urihttp://hdl.handle.net/10203/250487-
dc.description.abstractBrain metastasis in breast cancer is particularly deadly, but effective treatments remain out of reach due to insufficient information about the mechanisms underlying brain metastasis and the potential vulnerabilities of brain-metastatic breast cancer cells. Here, human breast cancer cells and their brain-metastatic derivatives (BrMs) were used to investigate synthetic lethal interactions in BrMs. First, it was demonstrated that c-MYC activity is increased in BrMs and is required for their brain-metastatic ability in a mouse xenograft model. Specifically, c-MYC enhanced brain metastasis by facilitating the following processes within the brain microenvironment: (i) invasive growth of BrMs, (ii) macrophage infiltration, and (iii) GAP junction formation between BrMs and astrocytes by upregulating connexin 43 (GJA1/Cx43). Furthermore, RNA-sequencing (RNA-seq) analysis uncovered a set of c-MYC–regulated genes whose expression is associated with higher risk for brain metastasis in breast cancer patients. Paradoxically, however, increased c-MYC activity in BrMs rendered them more susceptible to TRAIL (TNF-related apoptosis-inducing ligand)–induced apoptosis. In summary, these data not only reveal the brain metastasis-promoting role of c-MYC and a subsequent synthetic lethality with TRAIL, but also delineate the underlying mechanism. This suggests TRAIL-based approaches as potential therapeutic options for brain-metastatic breast cancer.-
dc.languageEnglish-
dc.publisherAMER ASSOC CANCER RESEARCH-
dc.titlec-MYC Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality with TRAIL-
dc.typeArticle-
dc.identifier.wosid000457397800019-
dc.identifier.scopusid2-s2.0-85060942898-
dc.type.rimsART-
dc.citation.volume17-
dc.citation.issue2-
dc.citation.beginningpage544-
dc.citation.endingpage554-
dc.citation.publicationnameMOLECULAR CANCER RESEARCH-
dc.identifier.doi10.1158/1541-7786.MCR-18-0630-
dc.contributor.localauthorKim, Pilnam-
dc.contributor.localauthorKim, Mi Young-
dc.contributor.nonIdAuthorKim, Seon Kyu-
dc.description.isOpenAccessN-
dc.type.journalArticleArticle-
Appears in Collection
BiS-Journal Papers(저널논문)BS-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 14 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0